
Last update at 2026-06-02T20:00:00Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
Investors in Redcare Pharmacy (ETR:RDC) have seen decent returns of 79% over the past five years
Thu 24 Apr 25, 12:32 PMEuropean Growth Companies With High Insider Ownership In April 2025
Tue 01 Apr 25, 10:05 AMEuropean Growth Stocks Insiders Are Betting On
Fri 28 Mar 25, 10:05 AMAnalysts Are Updating Their Redcare Pharmacy NV (ETR:RDC) Estimates After Its Yearly Results
Fri 14 Mar 25, 05:45 AMEuropean Value Stocks Trading Below Estimated Worth In March 2025
Thu 13 Mar 25, 05:08 AMRedcare Pharmacy Full Year 2024 Earnings: EPS Misses Expectations
Wed 12 Mar 25, 04:40 AMEuropean Growth Companies With High Insider Ownership
Thu 27 Feb 25, 05:05 AMWhen Will Redcare Pharmacy NV (ETR:RDC) Become Profitable?
Sun 16 Feb 25, 06:00 AMRedcare Pharmacy Independent Deputy Chairman of Supervisory Board Acquires 29% More Stock
Sun 26 Jan 25, 06:01 AM3 Growth Companies With Insider Ownership Up To 15%
Mon 20 Jan 25, 05:01 AM| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Income before tax | -84.11900M | -77.88400M | -15.93200M | -42.18000M | -34.59100M |
| Minority interest | - | - | - | - | - |
| Net income | -77.64600M | -74.18500M | -16.77100M | -36.27000M | -33.60900M |
| Selling general administrative | 244.24M | 196.88M | 145.24M | 108.71M | 81.42M |
| Selling and marketing expenses | - | - | - | - | - |
| Gross profit | 331.79M | 266.53M | 219.53M | 137.68M | 99.32M |
| Reconciled depreciation | 39.51M | 26.96M | 16.06M | 14.86M | 13.17M |
| Ebit | -47.23100M | -32.25000M | 5.56M | -28.43500M | -27.67100M |
| Ebitda | -36.10400M | -42.35400M | 10.55M | -19.83200M | -15.23400M |
| Depreciation and amortization | - | - | - | - | - |
| Non operating income net other | - | - | - | - | - |
| Operating income | -69.32100M | -43.40800M | -0.93100M | -34.18200M | -28.92500M |
| Other operating expenses | 0.15M | 0.16M | 0.07M | 0.15M | 0.20M |
| Interest expense | 8.50M | 8.57M | 10.41M | 7.48M | 6.18M |
| Tax provision | -6.47300M | -3.69900M | 0.84M | -5.91000M | -0.98200M |
| Interest income | 0.27M | 0.03M | 0.09M | 0.11M | 0.32M |
| Net interest income | -14.02900M | -13.09100M | -14.47900M | -10.03100M | -5.86100M |
| Extraordinary items | - | - | - | - | - |
| Non recurring | - | - | - | - | - |
| Other items | - | - | - | - | - |
| Income tax expense | -6.47300M | -3.69900M | 0.84M | -5.91000M | -0.98200M |
| Total revenue | 1204.35M | 1060.32M | 968.06M | 701.01M | 539.71M |
| Total operating expenses | 1273.67M | 1103.73M | 968.99M | 735.19M | 568.64M |
| Cost of revenue | 872.57M | 793.79M | 748.53M | 563.33M | 440.39M |
| Total other income expense net | - | - | - | - | - |
| Discontinued operations | - | - | - | - | - |
| Net income from continuing ops | -77.64600M | -74.18500M | -16.77100M | -36.27000M | -33.60900M |
| Net income applicable to common shares | -77.64600M | -74.18500M | -16.77100M | -36.27000M | -33.60900M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Total assets | 729.47M | 783.08M | 536.91M | 427.98M | 350.91M |
| Intangible assets | 119.43M | 104.35M | 75.54M | 70.73M | 63.30M |
| Earning assets | - | - | - | - | - |
| Other current assets | 12.35M | 12.45M | 9.90M | 8.50M | 6.14M |
| Total liab | 374.84M | 367.66M | 111.77M | 195.22M | 136.93M |
| Total stockholder equity | 354.63M | 415.41M | 425.14M | 232.76M | 213.98M |
| Deferred long term liab | - | - | - | - | 0.00500M |
| Other current liab | 4.18M | 3.18M | 2.21M | 0.98M | 2.50M |
| Common stock | 0.36M | 0.36M | 0.35M | 0.27M | 0.24M |
| Capital stock | 0.36M | 0.36M | 0.35M | 0.27M | 292.05M |
| Retained earnings | -285.42800M | -207.78200M | -133.72100M | -120.23000M | -83.96000M |
| Other liab | 28.19M | 22.15M | 4.35M | 3.90M | 10.84M |
| Good will | 169.57M | 153.13M | 129.12M | 129.12M | 129.29M |
| Other assets | 9.85M | 13.11M | 1.85M | 0.12M | 0.97M |
| Cash | 66.44M | 247.04M | 90.11M | 62.65M | 24.34M |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | 119.31M | 124.08M | 74.61M | 59.80M | 52.66M |
| Current deferred revenue | - | - | - | - | - |
| Net debt | 155.28M | - | - | 80.14M | 57.20M |
| Short term debt | - | - | - | - | - |
| Short long term debt | 1.67M | 1.66M | 0.04M | 15.43M | 13.89M |
| Short long term debt total | - | - | - | - | - |
| Other stockholder equity | 69.00M | 56.30M | 6.84M | 11.80M | 5.89M |
| Property plant equipment | 85.44M | 78.26M | 74.55M | 13.18M | 11.92M |
| Total current assets | 343.92M | 432.76M | 254.09M | 210.81M | 135.69M |
| Long term investments | - | - | - | - | - |
| Net tangible assets | 65.62M | 157.94M | 220.48M | 32.91M | 14.08M |
| Short term investments | 117.56M | 36.41M | 37.77M | 50.58M | 34.42M |
| Net receivables | 40.95M | 36.16M | 29.98M | 26.71M | 22.05M |
| Long term debt | 220.06M | 203.97M | 4.08M | 127.36M | 67.65M |
| Inventory | 99.71M | 96.62M | 81.24M | 56.69M | 43.35M |
| Accounts payable | 68.94M | 78.12M | 51.32M | 31.35M | 26.08M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | - | - | - | - | - |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | - | - | - | - |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | - | - | - | - |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | - | 0.00200M | - | 0.00100M | -0.00100M |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 385.56M | 350.31M | 282.82M | 217.16M | 214.20M |
| Capital lease obligations | 33.47M | 30.80M | 34.12M | 6.41M | 7.17M |
| Long term debt total | - | - | - | - | - |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Investments | -80.49300M | 2.41M | 13.08M | -18.65800M | -22.32300M |
| Change to liabilities | -12.24500M | 26.51M | 21.08M | 5.56M | 5.42M |
| Total cashflows from investing activities | -138.00900M | -84.29700M | -40.16400M | -33.40000M | -38.55700M |
| Net borrowings | -7.08400M | 223.75M | -12.52700M | 56.50M | 71.28M |
| Total cash from financing activities | -13.51500M | 229.59M | 50.19M | 102.44M | 66.50M |
| Change to operating activities | 0.62M | 23.97M | 5.94M | 5.94M | 5.94M |
| Net income | -77.64600M | -74.18500M | -16.77100M | -36.27000M | -33.60900M |
| Change in cash | -180.63600M | 156.93M | 27.83M | 38.31M | 13.42M |
| Begin period cash flow | 247.41M | 90.48M | 62.65M | 24.34M | 10.92M |
| End period cash flow | 66.78M | 247.41M | 90.48M | 62.65M | 14.53M |
| Total cash from operating activities | -29.11200M | 11.63M | 17.80M | -30.72800M | -14.52500M |
| Issuance of capital stock | 0.64M | 12.22M | 75.74M | 49.15M | - |
| Depreciation | 18.19M | 15.62M | 9.77M | 10.20M | 9.67M |
| Other cashflows from investing activities | 2.02M | -12.37000M | 0.09M | 0.09M | 0.09M |
| Dividends paid | - | - | - | - | - |
| Change to inventory | -3.08400M | -15.37500M | -24.55200M | -13.33900M | 0.13M |
| Change to account receivables | -2.27700M | -6.58100M | -3.69700M | -7.31400M | -5.17400M |
| Sale purchase of stock | - | - | - | - | - |
| Other cashflows from financing activities | -7.06800M | -6.37800M | -13.01800M | -3.20400M | -4.77800M |
| Change to netincome | 26.00M | 30.34M | 19.75M | 6.02M | 5.54M |
| Capital expenditures | 13.56M | 13.82M | 38.23M | 4.00M | 2.80M |
| Change receivables | - | - | - | - | - |
| Cash flows other operating | - | - | - | - | - |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | - | - | - | - | - |
| Change in working capital | -16.98100M | 28.52M | -1.23700M | -14.72700M | -9.42600M |
| Stock based compensation | 16.23M | 20.54M | 4.41M | 2.97M | - |
| Other non cash items | - | - | - | - | - |
| Free cash flow | -82.63600M | -31.52400M | -35.53300M | -45.10800M | -35.39600M |
Sector: Healthcare Industry: Pharmaceutical Retailers
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| SHPPF Shop Apotheke Europe N.V |
- -% | 45.18 | - | - | 2.80 | 2.28 | 1.70 | 78.78 |
| ALBHF Alibaba Health Information Technology Limited |
- -% | 0.48 | 36.00 | 19.01 | 0.36 | 3.63 | 1.73 | 25.72 |
| RADLY Raia Drogasil SA ADR |
-0.18 4.90% | 3.49 | 47.15 | 32.68 | 0.34 | 9.83 | 0.35 | 3.29 |
| ALBBY Alibaba Health Information Technology Limited |
0.27 2.85% | 9.75 | 34.43 | 19.84 | 0.29 | 3.79 | 1.73 | 25.72 |
| CLCGY Clicks Group Ltd |
-0.5 1.71% | 28.80 | 22.47 | 31.85 | 0.09 | 10.04 | 1.47 | 10.53 |
Redcare Pharmacy NV owns and operates online pharmacies in the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France. It provides prescription medications, over-the-counter medications, and pharmacy-related beauty and personal care products, as well as food supplements. The company was formerly known as Shop Apotheke Europe N.V. and changed its name to Redcare Pharmacy NV in June 2023. Redcare Pharmacy NV was founded in 2001 and is headquartered in Sevenum, the Netherlands.
Erik de Rodeweg 11?13, Sevenum, Netherlands, 5975 WD
| Name | Title | Year Born |
|---|---|---|
| Mr. Stefan Feltens | Chairman of the Managing Board & CEO | 1965 |
| Mr. Stephan Weber | Co-Founder, Chief Commercial Officer, Deputy CEO & Member of the Managing Board | 1979 |
| Mr. Marc Fischer | Co-Founder, Chief Information Officer & Member of the Managing Board | 1975 |
| Mr. Jasper F. P. Eenhorst | CFO & Member of Management Board | 1973 |
| Ms. Theresa Holler | COO & Member of the Managing Board | 1973 |
| Mr. Patrick Schneider | Chief Sales Officer | NA |
| Ms. Beate Krosch | Director of HR | NA |
| Mr. Nana Lohmanns | Chief E-Health Officer | NA |
| Mr. Dirk Bruse | Chief Brand Officer | NA |
| Mr. Jens Wolfgarten | Chief Product Officer - Retail | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.